Terbutaline sulfate 2.5 mg Oral Tablet
RxNorm 857677
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 857677 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: terbutaline sulfate 2.5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Terbutaline sulfate 2.5 mg Oral Tablet
(Atom ID: 12330526)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely terbutaline sulfate 2.5 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10317601)
PSNPrescribable
Prescribable Name (PSN):
Terbutaline sulfate 2.5 mg Oral Tablet
(Atom ID: 6366920)
PTPrescribable
Designated preferred name (PT):
Terbutaline sulfate 2.5 mg oral tablet
(Atom ID: 9264975)
Patient Education
Terbutaline
Terbutaline is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, and emphysema. Terbutaline is in a class of medications called beta agonists. It works by relaxing and opening the airways, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.